Clinical Trials Directory

Trials / Conditions / Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis

Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis

4 registered clinical trials studyying Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis — 1 currently recruiting.

StatusTrialSponsorPhase
CompletedMT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease
NCT06690242
Shaanxi Micot Pharmaceutical Technology Co., Ltd.Phase 2
RecruitingStudy of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidn
NCT06976177
Shaanxi Micot Pharmaceutical Technology Co., Ltd.Phase 2
UnknownInvestigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism i
NCT06236295
Shanghai Hengrui Pharmaceutical Co., Ltd.Phase 2
CompletedA Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Sec
NCT06747247
Shaanxi Micot Pharmaceutical Technology Co., Ltd.Phase 2